About
Kedi Mobile Inc. is an innovative digital health and AI startup revolutionizing healthcare accessibility through smart, data-driven solutions. Founded in 2021 at Muğla Technopark, the company develops mobile and bioinformatics applications that bridge clinical research and real-world healthcare.
Our flagship product, Orthodontist, is the world's first AI-powered pre-diagnosis software that enables early orthodontic diagnosis from a simple profile photo—currently used in 39 countries. The technology holds a national patent granted in Türkiye and a US patent pending (US20240252104A1).
Another major innovation, TCGAnalyzeR, is a precision oncology platform supporting pan-cancer analyses across 33 cancer types, facilitating early diagnosis, personalized treatment, and translational research with 2,200+ daily hits and 90 unique users worldwide.
Kedi Mobile has received funding and support from TÜBİTAK, KOSGEB, and the EU Horizon Women TechEU Programme. Combining academic rigor with entrepreneurial agility, the company integrates AI, bioinformatics, and digital health innovation to advance personalized medicine and empower clinicians, researchers, and patients alike.
Additional questions
Twinning role
Receiver institution – we have a concrete need and are looking to adopt or adapt a personalised medicine approach.Donor institution – we have a successful personalised medicine approach ready to share and support implementation elsewhere.